“Indian jab in my arms”,
Boris hails vaccine collaboration

0
4

By ANI special correspondent

NEW DELHI: British Prime Minister Boris Johnson on Friday highlighted the collaboration between Oxford-Astra Zeneca and the Serum Institute of India (SII) for the production of COVID-19 vaccines and emphasised that he has “the Indian jab” in his arms.   

Johnson made the remarks during a joint press meet with Prime Minister Narendra Modi.  SII CEO Adar Poonawala also met the British Prime Minister during the day.

The British Prime Minister referred to the collaboration between Oxford-Astra Zeneca and Pune-based Serum Institute of India (SII) for the production of the COVID-19 vaccine as an example of cooperation between the two countries.

British Prime Minister Boris Johnson and Indian premier Narinder Modi addressing a joint press conference in New Delhi.

“I have the Indian jab (manufactured by SII) in my arms and the power of good it did me so many thanks to India and that has helped India to become, what Narendra has called the ‘Pharmacy of the world’,” Johnson said.

Thanking the British PM for his remarks, Adar Poonawala said that his company remains committed to “providing world-class vaccines, globally.”

“Thank you Rt Hon. PM @BorisJohnson for your kind words emphasizing the successful India-UK partnership. It was a pleasure meeting you; we remain committed under the leadership of our PM Shri @NarendraModi Ji in providing world-class vaccines, globally,” Adar Poonawala said in a tweet.

Earlier today, Union Health Minister Mansukh Mandaviya said the Central government will engage with industry and academia to chalk aroadmap for pharma and medical devices for the next 25 years.

British Prime Minister Boris Johnson taking his first Covid-19 vaccination

The minister, who was addressing the media conference ahead of the 7th edition of India Pharmaceutical and Medical Devices Conference 2022, said India’s pharma industry has shown resilience during the COVID-19 pandemic. 

“Today, the Indian Pharma industry is at the threshold of rapid growth. We have already seen India as the pharmacy of the world and from our philosophy, we not only consider the pharmaceutical sector as a business but also as a ‘Seva’.”

“The Indian pharma industry is known globally for its affordable and quality drugs. We shall soon get the competitive edge in medical devices too with research and innovation,” he added.

New areas of cooperation,

investment opportunities in India 

Prime Minister Narendra Modi on Friday said that his talks with UK Prime Minister Boris Johnson were “wide-ranging and productive” and they also discussed new areas of cooperation.

Sectors such as trade, commerce, defence and clean energy figured prominently in the discussions

The Prime Minister said in tweets that they spoke about the reforms in India and the investment opportunities they bring.

The two leaders also held deliberations on strengthening the innovation ecosystem to benefit startups.

“My talks with PM @BorisJohnson were wide-ranging and productive. We took stock of the ground covered in the India-UK friendship and also discussed new areas of cooperation. Sectors such as trade, commerce, defence and clean energy figured prominently in our discussions,” the Prime Minister said.

“PM @BorisJohnson and I spoke about the reforms in India and the investment opportunities they bring. We also had deliberations on strengthening the innovation eco-system for the benefit of our youth and start-ups,” he added.

During the bilateral talks, both leaders agreed to transform defence and security cooperation as a key element of India-UK Comprehensive Strategic Partnership and discussed opportunities for defence collaboration including on co-development and co-production for meeting the needs of the armed forces of both the countries.

India and UK issued a Joint Statement for further intensifying cooperation on cyber security, particularly in the areas of cyber governance, cyber deterrence and safeguarding critical national infrastructure. They also agreed to closely cooperate on countering the persistent threat of terrorism and radical extremism. (ANI)